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A new way by which the potency of a eukaryotic
transcription factor can be regulated has been
discovered, in which nuclear factors increase the
concentration of the transcription factor’s active form
by modulating an otherwise unfavorable equilibrium
between monomeric and dimeric forms of the protein.
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It is a truth universally acknowledged that every
transcriptional event relies on formation of a protein–DNA
complex. Though the size of the ‘preinitiation complex’
for the transcription of eukaryotic protein-encoding genes
seems to grow daily, and a seemingly endless number of
synergistic interactions between and among upstream
binding proteins continue to be identified, each compo-
nent of these supramolecular complexes is connected —
directly or indirectly — to a DNA-binding transcription
factor bound to a specific sequence of DNA. The regula-
tion of transcription is dependent primarily on processes
that regulate either the probability that a DNA target
sequence is occupied by a regulatory factor, or the potency
of that factor once it is bound to its target.
Eukaryotic cells employ many mechanisms to alter the
potency of DNA-binding transcription factors in response
to cellular needs. Some mechanisms, such as changes in
expression or cellular location, are manifested by a change
in the nuclear concentration of the transcription factor and
consequently in promoter occupancy. Other mechanisms
of transcriptional regulation, such as phosphorylation or
proteolysis, alter the activity or the availability of the
factor’s transcriptional activation domain, and enhance its
potency independent of promoter occupancy. Recent
studies have now uncovered a third way by which the
potency of a eukaryotic transcription factor can be modu-
lated. These two new examples involve nuclear proteins
that modulate an otherwise unfavorable equilibrium
between the monomeric and dimeric forms of a DNA-
binding protein so as to increase the concentration of the
transcription factor’s active form. 
Many eukaryotic transcription factors form dimeric (2:1)
protein–DNA complexes. Examples include the proteins
characterised by having basic region leucine zipper (bZIP)
or basic region helix–loop–helix (bHLH) DNA-binding
domains, as well as many steroid hormone receptors and
members of the Rel family of transcription factors. Some
of these proteins exist in the nucleus as constitutive
dimers [1]; others are only able to dimerize as a result of
structural changes induced by DNA binding [2]. In some
cases, however, the equilibrium dissociation constant of
the dimer, and the estimated total protein concentration,
are such that the nucleus may be home to significant
levels of both monomeric and dimeric forms.
The monomer–dimer equilibrium offers an opportunity
to regulate the transcriptional machinery by using auxil-
iary proteins that increase the equilibrium stability of the
dimer and thereby the stability of the 2:1 protein–DNA
complex [3]. Auxiliary proteins with such properties
have been identified. For example, available data
suggest that the viral coactivators Tax [4–6] and pX [7,8]
interact with the DNA-contacting segments of DNA-
bound bZIP proteins so as to increase bZIP dimer stabil-
ity, and that this increase in stability translates into an
increase in the stability of the bZIP–DNA complex. The
cellular protein HMGI(Y) also enhances the level of
bZIP dimerization [9]. In essence, Tax, pX and
HMGI(Y) help prepare the bZIP and escort it to the
DNA, remaining in attendance while the bZIP protein
participates in the transcription ball (Figure 1a).
Given this precedent, it is not so surprising that a protein
has been identified in HeLa cells that can increase the sta-
bility of a bZIP dimer in the absence of DNA and thereby
enhance formation of the 2:1 protein–DNA complex. Vir-
basius et al. [10] have indeed discovered such a protein
which, like Tax and pX, increases the affinity of a bZIP
protein for DNA. This 32 kDa protein, known as ‘bZIP
enhancing factor’ (BEF), has features in common with the
viral cofactors, but displays fascinating and unexpected
differences as well. Like its viral counterparts, BEF
targets the DNA binding region of a bZIP protein and
shifts the bZIP monomer–dimer equilibrium in the
absence of DNA, promoting dimer formation. But unlike
Tax and pX, which interact with the bZIP basic segment,
BEF recognizes the actual dimerization element of the
bZIP domain — the leucine zipper. BEF is identical to
ALY, a previously identified [11] nuclear protein shown to
interact with, and influence the transcriptional potency of,
LEF-1 and AML-1 (which are, interestingly enough, not
bZIP proteins). 
The properties of BEF can be compared and contrasted
with the recently discovered properties of the ubiquitous
transcriptional coactivator TFIIA [12]. TFIIA binds to a
dimeric form of the TATA-binding protein (TBP) that
binds DNA poorly, and releases a form that binds DNA
well. Like BEF, TFIIA causes a shift in a
monomer–dimer equilibrium, but whereas BEF is
proposed to release the dimeric form of the bZIP protein,
TFIIA releases a monomeric form of TBP. 
The big surprise is that BEF is not simply an escort for the
bZIP protein, but also displays properties of a molecular
chaperone. DNA binding by bZIP proteins is sensitive to
chaperone activity — the well-studied chaperone GroEL
was found to enhance DNA binding by the bZIP protein
ATF-2 in an ATP-dependent manner [10]. That BEF
may promote DNA binding by a bZIP protein by virtue of
having chaperone-like activity is suggested by the obser-
vation that it displays an anti-aggregation activity and
forms an oligomeric complex of about 14 subunits. BEF is
perhaps an anomalous chaperone in two respects, though.
First, neither its effect on DNA binding by bZIP proteins
nor its activity in the anti-aggregation assay are dependent
on energy provided by ATP hydrolysis. Second, unlike
chaperones, which promote folding by avoiding off-
pathway aggregation events, BEF promotes the otherwise
unfavorable pathway to the properly folded molecule —
the bZIP dimer.
But how does BEF work to increase the affinity of a bZIP
protein for DNA? One possibility, proposed by Virbasius
et al. [10], is that BEF binds two bZIP monomers, assem-
bles the two monomers into a coiled-coil dimer, and
releases the dimer, which can then be trapped by DNA
(Figure 1b). This model is supported by the evidence that
bZIP dimers are stabilized by BEF. If the preformed
bZIP dimers are released into solution, as the authors
propose, they have (at least) two options: they can bind
DNA or dissociate into two bZIP monomers. At cellular
concentrations, it is likely that DNA binding — with rate
constants as high as 108 M–1 s–1 [13] — will occur at a
faster rate than dissociation — with rate constants
between 0.05 s–1 [13] and 0.003 s–1 [14] — and the dimer
will be trapped effectively by the available DNA. A simu-
lation [15] of the relative flux along these two pathways,
assuming a bZIP dimer concentration of 1 nM, shows that
more than 70% of the bZIP dimer is trapped as the
dimer–DNA complex at a DNA concentration of 5 nM,
assuming that the available DNA contains the appropriate
target site for formation of a sequence-specific 2:1
complex (Figure 2). 
If BEF does enhance bZIP binding by this mechanism,
how is the energy supplied? BEF is not an ATP-dependent
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Figure 1
Three possible mechanisms of action of
protein escorts for bZIP proteins. (a) The viral
escorts Tax or pX shift the bZIP
monomer—dimer equilibrium toward the dimer
and remain bound to the bZIP dimer–DNA
complex. The cellular escort BEF may (b) bind
two bZIP monomers, assemble them into a
coiled-coil dimer, and deliver them to the
DNA; or (c) bind a bZIP monomer–DNA
complex and facilitate dimerization on the
DNA. Kdim and Kdna are the equilibrium
dissociation constants of the bZIP dimer and
the bZIP dimer•DNA complexes, respectively;
Kmon1 and Kmon2 are the equilibrium
dissociation constants of the bZIP
monomer•DNA and bZIP dimer•DNA
complexes, respectively.
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chaperone, and it remains to be determined how the bZIP
dimer is released from BEF. In a slight variation of this
model, BEF could remain associated with the bZIP as it
binds DNA. In this case, release of BEF could be triggered
by DNA binding by the bZIP dimer, or by another interac-
tion of BEF. BEF has regions where the sequences suggest
similarity to RNA recognition motifs [11]. Interactions
between BEF and the nascent RNA transcript might both
trigger release of BEF from the transcriptional machinery
and increase the effective concentration of BEF–bZIP in
transcriptionally active regions of the genome. In other
words, BEF might not simply fold the bZIP into a confor-
mation suitable for DNA binding, but also usher it into a
waltz with key players at the transcription ball.
A second possible mechanism that can account for the
activity of BEF invokes an alternative pathway for assem-
bling a bZIP–DNA complex (Figure 1c). In the alterna-
tive pathway, two bZIP monomers bind DNA
sequentially and isomerize into a coiled-coil dimer while
bound to DNA [16]. Recent work has shown that this
pathway allows the bZIP to locate its target DNA more
rapidly than the pathway proceeding through a preformed
dimer, because it avoids long-lived yet non-productive
complexes between the bZIP dimer and non-specific
DNA [13]. BEF may bind the bZIP monomer–DNA
complex and aid dimer formation on the DNA, perhaps
by preorganizing the α helix of the leucine zipper in an
extended conformation (Figure 1c). According to this
model, BEF would protect the partially unfolded zipper
from proteolysis (and perhaps aggregation) and the bZIP
protein would retain the kinetic specificity provided by
the monomer binding pathway [13].
The identification of molecular escorts for DNA-binding
proteins opens many new areas of investigation. Are
these proteins essential for efficient transcriptional regu-
lation in vivo? Does BEF affect bZIP activity in an oblig-
ate way, or is its activity regulated as well? Is the newly
discovered activity of TFIIA regulated by interactions
with upstream activators? Do other escorts assist the
folding and delivery of other transcription factors? Do
Tax and pX also have chaperone activity? Questions of
mechanism and specificity abound: BEF lacks sequences
likely to fold into a helical template for coiled-coil forma-
tion; how then is the molecular surface of BEF tailored
to recognize so many different bZIP proteins, but not,
apparently, Gal4 (which, like bZIP proteins, contains a
coiled coil)? Does BEF actually promote folding and
dimerization, or does it function like a more traditional
chaperone, to avoid off-pathway folding events? And
finally, does BEF, like its viral counterparts, alter the set
of DNA sequences preferred by the bZIP protein? Only
time will tell if these new protein escorts participate in
locating (or even changing) the correct time and place of
the transcription ball.
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Figure 2
An illustration of how bZIP dimers released by BEF may be partitioned
between a pathway in which the dimer dissociates and one in which
the dimer is trapped by DNA. At low DNA concentrations very little of
the preformed dimer is trapped by DNA; when the DNA concentration
is increased to 5 nM, approximately 70% of the preformed dimer is
trapped as the (2:1) bZIP—DNA complex.
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